References
- Palacios S. Assessing symptomatic vulvar, vaginal, and lower urinary tract atrophy. Climacteric. 2019;22(4):348–351.
- Palacios S, Cancelo MJ, Castelo Branco C, et al. Vulvar and vaginal atrophy as viewed by Spanish revive participants: symptoms, management and treatment perceptions. Climacteric. 2017;20(1):55–61. Feb
- Nappi RE, Palacios S. Impact of vulvovaginal atrophy on postmenopausal sexual health and quality of life. Climacteric. 2014;17(1):3–9.
- Palacios S, Mejía A, Neyro JL. Treatment of the genitourinary syndrome of menopause. Climacteric. 2015;18(Suppl 1):23–29.
- Palacios S, Mejia A. Antiresorptive and anabolic therapy in sequence or combination for postmenopausal osteoporosis. Climacteric. 2015;18(4):453–455.
- Fernandes T, Costa-Paiva LH, Pedro AO, et al. Efficacy of vaginally applied estrogen, testosterone, or polyacrylic acid on vaginal atrophy: a randomized controlled trial. Menopause. 2016;23(7):792–798. Jul
- Sánchez S, Baquedano L, Cancelo MJ, et al. Managing vulvar and vestibular pain in postmenopausal women: recommendations from the Spanish menopause society, Spanish society of gynecology and obstetrics, Spanish society of primary care physicians and Spanish federation of sexology societies …. Gynecol Endocrinol. 2022;38(3):263–266. Mar
- Freedman MA. Perceptions of dyspareunia in postmenopausal women with vulvar and vaginal atrophy: findings from the REVIVE survey. Womens Health. 2014;10(4):445–454.
- Kingsberg SA, Wysocki S, Magnus L, et al. Vulvar and vaginal atrophy in postmenopausal women: findings from the revive (Real women’s views of treatment options for menopausal vaginal changes) survey. J Sex Med. 2013;10(7):1790–1799.
- Palacios S. Ospemifene for vulvar and vaginal atrophy: an overview. Drugs Context. 2020;9:2.
- Gambacciani M, Palacios S. Laser therapy for the restoration of vaginal function. Maturity. 2017;99:10–15.
- Nilsson S, Makela S, Treuter E, et al. Mechanisms of estrogen action. Physiol Rev. 2001;81(4):1535–1565.
- Meza-Muñoz DE, Fajardo ME, Perez-Luque EL, et al. Factors associated with estrogen receptors-alpha (ER-beta) and progesterone receptor abundance in obese and non-obese pre- and post-menopausal women. Steroids. 2006;71(6):498–503.
- Li S, Herrera GG, Tam KK, et al. Estrogen action in the epithelial cells of the mouse vagina regulates neutrophil infiltration and vaginal tissue integrity. Sci Rep. 2018;8(1):11247.
- Chung HS, Lee HS, Park K. Estrogen modulates epithelial progenitor cells in the rat vagina. Investig Clin Urol. 2021;62(3):349–353.
- Lethaby A, Ayeleke RO, Roberts H. Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev. 2016;2016(8):CD001500.
- Heo YA. Prasterone: a review in vulvovaginal atrophy. Drugs Aging. 2019;36(8):781–788.
- Lubián López DM. Management of genitourinary syndrome of menopause in breast cancer survivors: an update. World J Clin Oncol. 2022;13(2):71–100.
- Nappi RE, Palacios S, Panay N, et al. Vulvar and vaginal atrophy in four European countries: evidence from the European revive survey. Climacteric. 2016;19(2):188–197.